Elite Pharmaceuticals ELTP
OTC ELTP
$0.24 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:00 AM EDT

Elite Pharmaceuticals (ELTP) Shares Outstanding (Entity) (2010 - 2026)

Updated

Elite Pharmaceuticals (ELTP) posted Shares Outstanding (Entity) of 1.08 billion for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 0.6% from 1.07 billion a year earlier and unchanged from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends

Since fiscal Q1 2011, Elite Pharmaceuticals has reported Shares Outstanding (Entity) for 65 quarters.

  • Annual Shares Outstanding (Entity) shows a five-year compound annual growth rate of 1.3% (FY2021 to FY2026).
  • In prior fiscal years, Elite Pharmaceuticals' Shares Outstanding (Entity) was 1.07 billion in FY2025 (unchanged), 1.07 billion in FY2024 (+5.4%), 1.01 billion in FY2023 (+0.3%) and 1.01 billion in FY2022 (+0.2%).
  • The fiscal Q1 2027 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q1 2011.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last five quarters, with growth averaging 1.7% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.0% (fiscal Q1 2023) to 5.4% (fiscal Q2 2025).
  • According to Business Quant data, Shares Outstanding (Entity) for the three prior fiscal quarters was 1.08 billion (Q4 2026), 1.08 billion (Q3 2026) and 1.07 billion (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Eli Lilly 1,176.80 Bn 1,145.39 Bn 19.71 Bn 941.36 Mn
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn 2.41 Bn
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn 1.77 Bn
4 Merck 376.70 Bn 331.08 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn -
6 Astrazeneca 268.37 Bn 242.05 Bn 12.86 Bn -
7 Amgen 242.34 Bn 197.74 Bn 7.24 Bn 540.60 Mn
8 Gilead Sciences 193.58 Bn 167.78 Bn 6.22 Bn 1.24 Bn
9 Pfizer 172.88 Bn 119.53 Bn 10.94 Bn 5.70 Bn
10 Elite Pharmaceuticals 256.92 Mn 138.59 Mn 13.51 Mn 1.08 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.08 Bn
Mar 31, 2026 1.08 Bn
Dec 31, 2025 1.08 Bn
Sep 30, 2025 1.07 Bn
Jun 30, 2025 1.07 Bn
Mar 31, 2025 1.07 Bn
Dec 31, 2024 1.07 Bn
Sep 30, 2024 1.07 Bn
Jun 30, 2024 1.07 Bn
Mar 31, 2024 1.07 Bn
Dec 31, 2023 1.02 Bn
Sep 30, 2023 1.01 Bn
Jun 30, 2023 1.01 Bn
Mar 31, 2023 1.01 Bn
Dec 31, 2022 1.01 Bn
Sep 30, 2022 1.01 Bn
Jun 30, 2022 1.01 Bn
Mar 31, 2022 1.01 Bn
Dec 31, 2021 1.01 Bn
Sep 30, 2021 1.01 Bn
API Access

Elite Pharmaceuticals Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ELTP&period=max&api_key=YOUR_API_KEY